Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021

  • ID: 3989733
  • Report
  • Region: Global
  • 125 Pages
  • Markets and Markets
1 of 6
The Global Clinical Trial Imaging Market is Projected to Reach USD 1069.7 Million by 2021

FEATURED COMPANIES

  • Bioclinica, Inc.
  • Biotelemetry, Inc.
  • Icon PLC
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Radiant Sage LLC
  • MORE

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the clinical trial imaging market.

Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.

In this report, the global clinical trial imaging market is broadly segmented by product and service, modality, end user, and region. On the basis of product and service, the clinical trial imaging market is segmented into software and services. Services segment is classified into operational imaging services, reader services, systems & technology, and design consulting. The service segment is expected to account for the largest share of the clinical trial imaging market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities. In 2016, the CT segment is expected to account for the largest share of the global clinical trial imaging market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body.

On the basis of end user, the clinical trial imaging market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users. In 2016, Pharmaceutical companies form the largest end-user segment of the clinical trial imaging market. Increased R&D budgets of pharmaceutical companies are the primary growth driver for this end-user segment.

Collaboration, Partnership, and Agreement was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the clinical trial imaging market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to buy this report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the single-use bioprocessing market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  •  Market Penetration: Comprehensive information on products offered by the top players in the clinical trial imaging market
  •  Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the clinical trial imaging market
  •  Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for clinical trial imaging products across various regions
  •  Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the clinical trial imaging market
  •  Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the clinical trial imaging market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Bioclinica, Inc.
  • Biotelemetry, Inc.
  • Icon PLC
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Radiant Sage LLC
  • MORE
1 Introduction 
1.1 Objectives of the Study 

1.2 Market Definition 

1.3 Market Scope 

1.3.1 Markets Covered 

1.3.2 Years Considered in the Study 

1.4 Currency 

1.5 Limitation 

1.6 Stakeholders 

2 Research Methodology 
2.1 Market Size Estimation 

2.2 Market Breakdown and Data Triangulation 

2.3 Market Rank Estimation 

2.3.1 Key Data from Secondary Sources 

2.3.2 Key Data from Primary Sources 

2.3.3 Key Industry Insights 

2.3.4 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 
4.1 Clinical Trial Imaging: Market Overview 

4.2 Clinical Trial Imaging Market, by Product & Service, 2016 

4.3 Clinical Trial Imaging Market Size, by Modality, 2016 vs. 2021 

4.4 Clinical Trial Imaging Market Size, by End User, 2016 vs. 2021 

4.5 Geographic Snapshot of the Clinical Trial Imaging Market 

4.6 Life Cycle Analysis, by Region 

5 Market Overview 
5.1 Introduction 

5.2 Market Dynamics 

5.2.1 Drivers 

5.2.1.1 Increase in R&D Spending 

5.2.1.2 Growth in the Pharmaceutical and Biotechnology Industries 

5.2.1.3 Increasing Number of Cros 

5.2.2 Restraints 

5.2.2.1 High Implementation Cost of Imaging Systems 

5.2.3 Opportunities 

5.2.3.1 Emerging Economies 

5.2.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals 

5.2.4 Challenges 

5.2.4.1 High Cost of Clinical Trials 

5.2.4.2 High Cost of PET 

5.3 Recent Market Trends 

5.3.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials 

5.4 Regulatory Scenario 

5.5 Clinical Trials: Global Scenario 

6 Clinical Trial Imaging Market, by Product and Service 
6.1 Introduction 

6.2 Services 

6.2.1 Operational Imaging Services 

6.2.2 Read Analysis Services 

6.2.3 System and Technical Support Services 

6.2.4 Trial Design Consulting Services 

6.3 Software 

7 Clinical Trial Imaging Market, by Modality 
7.1 Introduction 

7.2 Computed Tomography 

7.3 Magnetic Resonance Imaging 

7.4 Ultrasound 

7.5 Positron Emission Tomography 

7.6 X-Ray 

7.7 Echocardiography 

7.8 Other Modalities 

8 Clinical Trial Imaging Market, by End User 
8.1 Introduction 

8.2 Pharmaceutical Companies 

8.3 Biotechnology Companies 

8.4 Medical Device Manufacturers 

8.5 Contract Research Organizations 

8.6 Academic and Government Research Institutes 

8.7 Other End Users 

9 Clinical Trial Imaging Market, by Region 
9.1 Introduction 

9.2 North America 

9.2.1 U.S. 

9.2.2 Canada 

9.3 Europe 

9.4 Asia 

9.5 Rest of the World (RoW) 

10 Competitive Landscape 
10.1 Introduction 

10.2 Strategic Overview 

10.3 Competitive Situation and Trends 

10.4 Leading Players in the Clinical Trial Imaging Market 

10.4.1 Agreements, Collaborations, and Partnerships 

10.4.2 Expansion 

10.4.3 Acquisition 

10.4.4 Product and Service Launches & Product Upgrades 

11 Company Profiles 
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MNM View) -
11.1 Introduction 

11.2 Bioclinica, Inc. 

11.3 Parexel International Corporation 

11.4 Icon PLC 

11.5 Biomedical Systems Corporation 

11.6 Biotelemetry, Inc. 

11.7 Cardiovascular Imaging Technologies, LLC 

11.8 Intrinsic Imaging LLC 

11.9 Ixico PLC 

11.10 Radiant Sage LLC 

11.11 Worldcare Clinical, LLC 

12 Appendix 
12.1 Insights of Industry Experts 

12.2 Discussion Guide 

12.3 Other Developments 

12.4 Knowledge Store
12.5 Introducing RT: Real-Time Market Intelligence 

12.6 Available Customizations 

12.7 Related Reports 

12.8 Author Details 

List of Tables:
Table 1 Phases of Clinical Trials 

Table 2 Global Scenario of Clinical Trials Till 2015 

Table 3 Clinical Trial Imaging Market Size, by Product and Service, 2014-2021 (USD Million) 

Table 4 Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 5 Clinical Trial Imaging Services Market Size, by Region, 2014-2021 (USD Million) 

Table 6 North America: Clinical Trial Imaging Services Market Size, by Country, 2014-2021 (USD Million) 

Table 7 Operational Imaging Services Market Size, by Region, 2014-2021 (USD Million) 

Table 8 North America: Operational Imaging Services Market Size, by Country, 2014-2021 (USD Million) 

Table 9 Read Analysis Services Market Size, by Region, 2014-2021 (USD Million) 

Table 10 North America: Read Analysis Services Market Size, by Country, 2014-2021 (USD Million) 

Table 11 System and Technical Support Services Market Size, by Region, 2014-2021 (USD Million) 

Table 12 North America: System and Technical Support Services Market Size, by Country, 2014-2021 (USD Million) 

Table 13 Trial Design Consulting Services Market Size, by Region, 2014-2021 (USD Million) 

Table 14 North America: Trial Design Consulting Services Market Size, by Country, 2014-2021 (USD Million) 

Table 15 Clinical Trial Imaging Software Market Size, by Region, 2014-2021 (USD Million) 

Table 16 North America: Clinical Trial Imaging Software Market Size, by Country, 2014-2021 (USD Million) 

Table 17 Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 18 Clinical Trial Imaging Market Size for Ct, by Region, 2014-2021 (USD Million) 

Table 19 North America: Clinical Trial Imaging Market Size for Ct, by Country, 2014-2021 (USD Million) 

Table 20 Clinical Trial Imaging Market Size for Mri, by Region, 2014-2021 (USD Million) 

Table 21 North America: Clinical Trial Imaging Market Size for Mri, by Country, 2014-2021 (USD Million) 

Table 22 Clinical Trial Imaging Market Size for Ultrasound, by Region, 2014-2021 (USD Million) 

Table 23 North America: Clinical Trial Imaging Market Size for Ultrasound, by Country, 2014-2021 (USD Million) 

Table 24 Clinical Trial Imaging Market Size for Pet, by Region, 2014-2021 (USD Million) 

Table 25 North America: Clinical Trial Imaging Market Size for Pet, by Country, 2014-2021 (USD Million) 

Table 26 Clinical Trial Imaging Market Size for X-Ray, by Region, 2014-2021 (USD Million) 

Table 27 North America: Clinical Trial Imaging Market Size for X-Ray, by Country, 2014-2021 (USD Million) 

Table 28 Clinical Trial Imaging Market Size for Echocardiography, by Region, 2014-2021 (USD Million) 

Table 29 North America: Clinical Trial Imaging Market Size for Echocardiography, by Country, 2014-2021 (USD Million) 

Table 30 Clinical Trial Imaging Market Size for Other Modalities, by Region, 2014-2021 (USD Million) 

Table 31 North America: Clinical Trial Imaging Market Size for Other Modalities, by Country, 2014-2021 (USD Million) 

Table 32 Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 33 Clinical Trial Imaging Market Size, by Region, 2014-2021 (USD Million) 

Table 34 North America: Clinical Trial Imaging Market Size, by Country, 2014-2021 (USD Million) 

Table 35 Clinical Trial Imaging Market Size for Pharmaceutical Companies, by Region, 2014-2021 (USD Million) 

Table 36 North America: Clinical Trial Imaging Market Size for Pharmaceutical Companies, by Country, 2014-2021 (USD Million) 

Table 37 Clinical Trial Imaging Market Size for Biotechnology Companies, by Region, 2014-2021 (USD Million) 

Table 38 North America: Clinical Trial Imaging Market Size for Biotechnology Companies, by Country, 2014-2021 (USD Million) 

Table 39 Clinical Trial Imaging Market Size for Medical Device Manufacturers, by Region, 2014-2021 (USD Million) 

Table 40 North America: Clinical Trial Imaging Market Size for Medical Device Manufacturers, by Country, 2014-2021 (USD Million) 

Table 41 Clinical Trial Imaging Market Size for Contract Research Organizations, by Region, 2014-2021 (USD Million) 

Table 42 North America: Clinical Trial Imaging Market Size for Contract Research Organizations , by Country, 2014-2021 (USD Million) 

Table 43 Clinical Trial Imaging Market Size for Academic and Government Research Institutes, by Region, 2014-2021 (USD Million) 

Table 44 North America: Clinical Trial Imaging Market Size for Academic and Government Research Institutes, by Country, 2014-2021 (USD Million) 

Table 45 Clinical Trial Imaging Market Size for Other End Users, by Region, 2014-2021 (USD Million) 

Table 46 North America: Clinical Trial Imaging Market Size for Other End Users, by Country, 2014-2021 (USD Million) 

Table 47 Clinical Trial Imaging Market Size, by Region, 2014-2021 (USD Million) 

Table 48 North America: Clinical Trial Imaging Market Size, by Country, 2014-2021 (USD Million) 

Table 49 North America: Clinical Trial Imaging Market Size, by Product & Service, 2014-2021 (USD Million) 

Table 50 North America: Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 51 North America: Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 52 North America: Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 53 U.S.: Clinical Trial Imaging Market Size, by Product & Service, 2014-2021 (USD Million) 

Table 54 U.S.: Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 55 U.S.: Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 56 U.S.: Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 57 Canada: Clinical Trial Imaging Market Size, by Product & Service, 2014-2021 (USD Million) 

Table 58 Canada: Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 59 Canada: Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 60 Canada: Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 61 Europe: Clinical Trial Imaging Market Size, by Product & Service, 2014-2021 (USD Million) 

Table 62 Europe: Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 63 Europe: Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 64 Europe: Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 65 Asia: Clinical Trial Imaging Market Size, by Product & Service, 2014-2021 (USD Million) 

Table 66 Asia: Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 67 Asia: Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 68 Asia: Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 69 Row: Clinical Trial Imaging Market Size, by Product & Service, 2014-2021 (USD Million) 

Table 70 Row: Clinical Trial Imaging Services Market Size, by Type, 2014-2021 (USD Million) 

Table 71 Row: Clinical Trial Imaging Market Size, by Modality, 2014-2021 (USD Million) 

Table 72 Row: Clinical Trial Imaging Market Size, by End User, 2014-2021 (USD Million) 

Table 73 Rank of Companies in the Global Clinical Trial Imaging Market, 2015 

Table 74 Agreements, Collaborations, and Partnerships, 2013-2016 

Table 75 Expansions, 2013-2016 

Table 76 Acquisitions, 2013-2016 

Table 77 Product and Service Launches & Product Upgrades, 2013-2016 

List of Figures:
Figure 1 Clinical Trial Imaging Market Segmentation 

Figure 2 Research Design 

Figure 3 Market Size Estimation Methodology: Bottom-Up Approach 

Figure 4 Market Size Estimation Methodology: Top-Down Approach 

Figure 5 Breakdown of Primary Interviews: by Company Type, Designation, and Region 

Figure 6 Data Triangulation Methodology 

Figure 7 Clinical Trial Imaging Market Size, by Product & Service, 2016 vs. 2021 (USD Million) 

Figure 8 Clinical Trial Imaging Market Size, by Modality, 2016 vs. 2021 (USD Million) 

Figure 9 Clinical Trial Imaging Market Size, by End User, 2016 vs. 2021 (USD Million) 

Figure 10 Geographic Snapshot of the Clinical Trial Imaging Market 

Figure 11 Emerging Economies Offer Significant Growth Opportunities for Players in the Clinical Trial Imaging Market 

Figure 12 Services Segment To Account for the Largest Share of the Clinical Trial Imaging Market in 2016 

Figure 13 PET Modality Segment To Register the Highest Cagr During the Forecast Period 

Figure 14 Pharmaceutical Companies To Account for the Largest Market Share in 2016 

Figure 15 Asia To Register the Highest Growth Rate from 2016 To 2021 

Figure 16 Asia Offers Significant Growth Opportunities in the Forecast Period 

Figure 17 Increase in R&D Spending Will Drive the Growth of the Clinical Trial Imaging Market 

Figure 18 Clinical Trial Imaging Services To Form the Largest Segment in 2016 

Figure 19 Ct Segment To Dominate the Clinical Trial Imaging Market in 2016 

Figure 20 Pharmaceutical Companies To Account for the Largest Share of the Clinical Trial Imaging Market in 2016 

Figure 21 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, by Region 

Figure 22 North America To Dominate the Clinical Trial Imaging Market During the Forecast Period 

Figure 23 Clinical Trial Imaging Market in Asia Expected To Grow At the Highest Rate During the Forecast Period 

Figure 24 North America: Clinical Trial Imaging Market Snapshot 

Figure 25 Asia: Clinical Trial Imaging Market Snapshot 

Figure 26 Agreements, Partnerships, and Collaborations Is the Key Growth Strategy Adopted by Players in the Clinical Trials Imaging Market 

Figure 27 Battle for Market Share: Agreements, Collaborations, and Partnerships: the Key Strategies Adopted by Players Between January 2013 and October 2016 

Figure 28 Geographic Revenue Mix of the Top Three Market Players 

Figure 30 Company Snapshot: Parexel International Corporation 

Figure 31 Company Snapshot: Icon PLC 

Figure 32 Company Snapshot: Biotelemetry, Inc. 

Figure 33 Company Snapshot: Ixico PLC
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • Icon PLC
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Parexel International Corporation
  • Radiant Sage LLC
  • Worldcare Clinical, LL
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll